Advertisement

Cell and Tissue Research

, Volume 331, Issue 1, pp 67–78 | Cite as

Immunogenicity of human embryonic stem cells

  • Karl-Henrik GrinnemoEmail author
  • Christer Sylvén
  • Outi Hovatta
  • Göran Dellgren
  • Matthias Corbascio
Review

Abstract

Human embryonic stem cells (HESC) are pluripotent stem cells isolated from the inner cell mass of human blastocysts. With the first successful culturing of HESC, a new era of regenerative medicine was born. HESC can differentiate into almost any cell type and, in the future, might replace solid organ transplantation and even be used to treat progressive degenerative diseases such as Parkinson’s disease. Although this sounds promising, certain obstacles remain with regard to their clinical use, such as culturing HESC under well-defined conditions without exposure to animal proteins, the risk of teratoma development and finally the avoidance of immune rejection. In this review, we discuss the immunological properties of HESC and various strategic solutions to circumvent immune rejection, such as stem cell banking, somatic cell nuclear transfer and the induction of tolerance by co-stimulation blockade and mixed chimerism.

Keywords

Embryonic stem cells Immunogenicity Immune-privilege Rejection Immunotolerance 

References

  1. Anderson D, Billingham RE, Lampkin GH, Medawar PB (1951) The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 5:379–397Google Scholar
  2. Becker YT, Becker BN, Pirsch JD, Sollinger HW (2004) Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 4:996–1001PubMedCrossRefGoogle Scholar
  3. Billingham RE, Lampkin GH, Medawar PB, Williams HLI (1952) Tolerance to homografts, twin diagnosis and the freemartin condition in cattle. Heredity 6:201–212Google Scholar
  4. Bonde S, Zavazava N (2006) Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24:2192–2201PubMedCrossRefGoogle Scholar
  5. Bradley JA, Bolton EM, Pedersen RA (2002) Stem cell medicine encounters the immune system. Nat Rev Immunol 2:859–871PubMedCrossRefGoogle Scholar
  6. Burt RK, Verda L, Kim DA, Oyama Y, Luo K, Link C (2004) Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J Exp Med 199:895–904PubMedCrossRefGoogle Scholar
  7. Caballero A, Fernandez N, Lavado R, Bravo MJ, Miranda JM, Alonso A (2006) Tolerogenic response: allorecognition pathways. Transpl Immunol 17:3–6PubMedCrossRefGoogle Scholar
  8. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS (2001) Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172:383–397PubMedCrossRefGoogle Scholar
  9. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A, Bhatia M (2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:906–915PubMedCrossRefGoogle Scholar
  10. Cibelli JB, Campbell KH, Seidel GE, West MD, Lanza RP (2002) The health profile of cloned animals. Nat Biotechnol 20:13–14PubMedCrossRefGoogle Scholar
  11. Clausen H, Hakomori S (1989) ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 56:1–20PubMedCrossRefGoogle Scholar
  12. Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F (1998) Rituximab for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 92:1927PubMedGoogle Scholar
  13. Cooper DK (1990) Clinical survey of heart transplantation between ABO blood-group-incompatible recipients and donors. J Heart Transplant 9:376–381PubMedGoogle Scholar
  14. Corbascio M, Mahanty H, Osterholm C, Qi Z, Pearson TC, Larsen CP, Freise CE, Ekberg H (2002) Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. Transplantation 74:35–41PubMedCrossRefGoogle Scholar
  15. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99:9864–9869PubMedCrossRefGoogle Scholar
  16. Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N (2006) Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24:221–229PubMedCrossRefGoogle Scholar
  17. Ellerstrom C, Strehl R, Moya K, Andersson K, Bergh C, Lundin K, Hyllner J, Semb H (2006) Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24:2170–2176PubMedCrossRefGoogle Scholar
  18. Elwood ET, Larsen CP, Cho HR, Corbascio M, Ritchie SC, Alexander DZ, Tucker-Burden C, Linsley PS, Aruffo A, Hollenbaugh D, Winn KJ, Pearson TC (1998) Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 65:1422–1428PubMedCrossRefGoogle Scholar
  19. Fairchild PJ (1998) Presentation of antigenic peptides by products of the major histocompatibility complex. J Peptide Sci 4:182–194CrossRefGoogle Scholar
  20. Fändrich F, Lin X, Chai GX, Schulze M, Ganten D, Bader M, Holle J, Huang DS, Parwaresch R, Zavazava N, Binas B (2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171–178PubMedCrossRefGoogle Scholar
  21. Frasca L, Marelli-Berg F, Imami N, Potolicchio I, Carmichael P, Lombardi G, Lechler R (1998) Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 53:679–689PubMedCrossRefGoogle Scholar
  22. Genberg H, Hansson A, Wernerson A, Wennberg L, Tydén G (2006) Pharmacodynamics of Rituximab in kidney allotransplantation.Am J Transplant 6:2418–2428PubMedCrossRefGoogle Scholar
  23. Grinnemo KH, Kumagai-Braesch M, Månsson-Broberg A, Skottman H, Hao X, Siddiqui A, Andersson A, Strömberg AM, Lahesmaa R, Hovatta O, Sylven C, Corbascio M, Dellgren G (2006) Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 13:712–724PubMedGoogle Scholar
  24. Hovatta O, Mikkola M, Gertow K, Stromberg AM, Inzunza J, Hreinsson J, Rozell B, Blennow E, Andang M, Ahrlund-Richter L (2003) A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 18:1404–1409PubMedCrossRefGoogle Scholar
  25. Ilstad ST, Sachs DH (1984) Reconstitution with syngeneic and allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168–170CrossRefGoogle Scholar
  26. Ilstad ST, Wren S, Bluestone JA, Barbieri SA, Sachs DH (1985) Characterisation of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med 162:231–244CrossRefGoogle Scholar
  27. Inzunza J, Gertow K, Stromberg AM, Matilainen E, Blennow E, Skottman H, Wolbank S, Ahrlund-Richter L, Hovatta O (2005) Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23:544–549PubMedCrossRefGoogle Scholar
  28. Itescu S, Tung TC, Burke EM, Weinberg A, Moazami N, Artrip JH, Suciu-Foca N, Rose EA, Oz MC, Michler RE (1998) Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98:786–793PubMedGoogle Scholar
  29. Ito N, Hirota T (1992) Histochemical and cytochemical localisation of blood-group antigens. Prog Histochem Cytochem 25:1–85PubMedGoogle Scholar
  30. Janeway CA Jr (1999) The role of self-recognition in receptor repertoire development. Members of the Janeway laboratory. Immunol Res 19:107–118PubMedGoogle Scholar
  31. Janeway CA Jr, Ron J, Katz ME (1987) The B cell is the initiating antigen presenting cell in peripheral lymph nodes. J Immunol 138:1051–1055PubMedGoogle Scholar
  32. Johnson MA, Weick JP, Pearce RA, Zhang SC (2007) Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci 27:3069–3077PubMedCrossRefGoogle Scholar
  33. Kaech SM, Wherry EJ, Ahmed R (2002) Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2:251–262PubMedCrossRefGoogle Scholar
  34. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716–10721PubMedCrossRefGoogle Scholar
  35. Kennedy D (2006) Editorial retraction (Letter). Science 311:335PubMedCrossRefGoogle Scholar
  36. Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R (2005) Human embryonic stem cells derived without feeder cells. Lancet 365:1636–1641PubMedCrossRefGoogle Scholar
  37. Koivisto H, Hyvarinen M, Stromberg AM, Inzunza J, Matilainen E, Mikkola M, Hovatta O, Teerijoki H (2004) Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reprod Biomed Online 9:330–337PubMedCrossRefGoogle Scholar
  38. Kumagai-Braesch M, Ekberg J, Holgersson J, Corbascio M (2007) Anti-LFA-1 improves pig islet function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L. Transplantation (in press)Google Scholar
  39. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434–438PubMedCrossRefGoogle Scholar
  40. Larsson LC, Corbascio M, Pearson TC, Larsen CP, Ekberg H, Widner H (2003) Induction of operational tolerance to discordant dopaminergic porcine xenografts. Transplantation 75:1448–1454PubMedCrossRefGoogle Scholar
  41. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R (2002) Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391–4396PubMedCrossRefGoogle Scholar
  42. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J, Bhatia M (2004) Human embryonic stem cells possess immune-privileged properties. Stem Cells 22:448–456PubMedCrossRefGoogle Scholar
  43. Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA, Thomson JA (2006) Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185–187PubMedCrossRefGoogle Scholar
  44. Magliocca JF, Held IKA, Odorico JS (2006) Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 15:707–717PubMedCrossRefGoogle Scholar
  45. Maloney D, Liles T, Czerwinski D, Waldichuk C, Rosenberg J, Grillo-Lopez A, Levy R (1994) Phase I clinical trial using escalating single dose infusion of chimeric anti-CD20 monoclonal antibody in patients with recurrent B-cell lymphoma. Blood 84:2457PubMedGoogle Scholar
  46. Martin MJ, Muotri A, Gage F, Varki A (2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11:228–232PubMedCrossRefGoogle Scholar
  47. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, Brink S van den, Hassink R, Heyden M van der, Opthof T, Pera M, Riviere AB de la, Passier R, Tertoolen L (2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107:2733–2740PubMedCrossRefGoogle Scholar
  48. Nadler LM, Ritz J, Hardy R, Pesando JM, Schlossman SF, Stashenko P (1981) A unique cell surface antigen identifying lymphoid malignancies of B-cell origin. J Clin Invest 67:134PubMedGoogle Scholar
  49. Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J (1999) HLA compatibility and organ transplant survival. Collaborant transplant study. Rev Immunogenet 1:334–342PubMedGoogle Scholar
  50. Owen RD (1945) Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400–401PubMedCrossRefGoogle Scholar
  51. Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735–739PubMedCrossRefGoogle Scholar
  52. Paul LC, Baldwin WM (1987) Humoral rejection mechanisms and ABO incompatibility in renal transplantation. Transplant Proc 19:4463–4467PubMedGoogle Scholar
  53. Penn I (2000) Post-transplant malignancy: the role of immunosuppression. Drug Safety 23:101–113PubMedCrossRefGoogle Scholar
  54. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, Martin PJ, Hansen JA (1997) Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89:1818–1823PubMedGoogle Scholar
  55. Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Michelson EM, Woolfrey AE, Hansen JA (1998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92:3515–3520PubMedGoogle Scholar
  56. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK (2003) Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 12:1–11PubMedGoogle Scholar
  57. Rasetter W, Molina A, White CA (2004) Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 55:477–503CrossRefGoogle Scholar
  58. Rathjen J, Rathjen PD (2001) Mouse ES cells: experimental exploitation of pluripotent differentiation potential. Curr Opin Genet Dev 11:587–594PubMedCrossRefGoogle Scholar
  59. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399–404PubMedCrossRefGoogle Scholar
  60. Reubinoff BE, Itsykson P, Tyretski T, Pera MF, Reinhartz E, Itzik A, Ben-Hur T (2001) Neural progenitors from human embryonic stem cells. Nat Biotechnol 19:1134–1140PubMedCrossRefGoogle Scholar
  61. Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD (2007) Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918–928PubMedCrossRefGoogle Scholar
  62. Rogers NJ, Lechler RI (2001) Allorecognition. Am J Transplant 1:97–102PubMedCrossRefGoogle Scholar
  63. Schulz T, Palmarini GM, Noggle SA, Weiler DA, Mitalipova MM, Condie BG (2003) Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci 22:27CrossRefGoogle Scholar
  64. Sharabi Y, Sachs DH (1989) Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 169:493–502PubMedCrossRefGoogle Scholar
  65. Simon DM, Levin S (2001) Infectious complications of solid organ transplantations. Infect Dis Clin North Am 15:521–549PubMedCrossRefGoogle Scholar
  66. Simpson E, Scott D, James E, Lombardi G, Cwynarski K, Dazzi F, Millrain JM, Dyson PJ (2001) Minor H antigens: genes and peptides. Eur J Immunogenet 28:505–513PubMedCrossRefGoogle Scholar
  67. Snell GD (1964) Methods for study of histocompatibility genes and isoantigens. Methods Med Res 10:1–7PubMedGoogle Scholar
  68. Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King KE, Shirey RS, Simpkins CE, Montgomery RA (2004) Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4:1316–1322CrossRefGoogle Scholar
  69. Stojkovic P, Lako M, Przyborski S, Stewart R, Armstrong L, Evans J, Zhang X, Stojkovic M (2005) Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 23:895–902PubMedCrossRefGoogle Scholar
  70. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Waltz DA, Kech BM, Hertz MI (2006) Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report–2006. J Heart Lung Transplant 25:869–879PubMedCrossRefGoogle Scholar
  71. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147PubMedCrossRefGoogle Scholar
  72. Tomita Y, Sachs DH, Khan A, Sykes M (1996) Additional mAb injections can replace thymic irradiation to allow induction of chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T-cell mAbs and 3 Gy whole body irradiation. Transplantation 61:469–477PubMedCrossRefGoogle Scholar
  73. Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, Ha J, Durham MM, Corbascio M, Cowan SR, Pearson TC, Larsen CP (1999) Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 104:1715–1722PubMedCrossRefGoogle Scholar
  74. Tsokos GC (2004) B-cells, be gone—B-cell depletion in the treatment of reumatoid arthritis. N Eng J Med 350:2546–2548CrossRefGoogle Scholar
  75. Tydén G, Kumlien G, Fehrman I (2003) Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoabsorption and Rituximab. Transplantation 76:730–731PubMedCrossRefGoogle Scholar
  76. Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I (2005) ABO incompatible kidney transplantation without splenectomy, using antigen-specific immunoabsorption and Rituximab. Am J Transplant 5:145–148PubMedCrossRefGoogle Scholar
  77. Viret C, Janeway CA Jr (1999) MHC and T cell development. Rev Immunogenet 1:91–104PubMedGoogle Scholar
  78. Wakayama T, Tabar V, Rodriguez I, Perry AC, Studer L, Mombaerts P (2001) Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292:740–743PubMedCrossRefGoogle Scholar
  79. Wang L, Duan E, Sung LY, Jeong BS, Yang X, Tian XC (2005) Generation and characterization of pluripotent stem cells from cloned bovine embryos. Biol Reprod 73:149–155PubMedCrossRefGoogle Scholar
  80. Wekerle T, Sykes M (2001) Mixed chimerism and transplantation tolerance. Annu Rev Med 52:353–370PubMedCrossRefGoogle Scholar
  81. Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, Swenson KG, Zhao G, Sykes M (1999) Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 68:1348–1355PubMedCrossRefGoogle Scholar
  82. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M (2000) Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6:464–469PubMedCrossRefGoogle Scholar
  83. Xu C, Police S, Rao N, Carpenter MK (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91:501–508PubMedCrossRefGoogle Scholar
  84. Zhan X, Dravid G, Ye Z, Hammond H, Shamblott M, Gearhart J, Cheng L (2004) Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 364:163–171PubMedCrossRefGoogle Scholar
  85. Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129–1133PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Karl-Henrik Grinnemo
    • 1
    Email author
  • Christer Sylvén
    • 2
  • Outi Hovatta
    • 3
  • Göran Dellgren
    • 1
  • Matthias Corbascio
    • 4
  1. 1.Division of Cardiothoracic Surgery and Anaesthesiology, Department of Molecular Medicine and SurgeryKarolinska Institute, Karolinska University HospitalStockholmSweden
  2. 2.Division of Cardiology, Department of MedicineKarolinska Institute, Karolinska University HospitalStockholmSweden
  3. 3.Department of Clinical Sciences, Intervention and TechnologyKarolinska Institute, Karolinska University HospitalStockholmSweden
  4. 4.Department of Heart DiseasesCardiothoracic Surgery, Haukelands University HospitalBergenNorway

Personalised recommendations